Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03923556 · ClinicalTrials.gov registry record · Phase 4
Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery
A Phase 4 study of Kidney Transplant; Complications and Postoperative Residual Curarization, sponsored by University of Colorado, Denver.
- Completed
- Registry status
- Phase 4
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT03923556 is a Phase 4 study of Kidney Transplant; Complications and Postoperative Residual Curarization that has completed, run by University of Colorado, Denver. The registered enrollment target is 84 participants, below the 117-participant average among 19 other Kidney Transplant; Complications trials with a reported enrollment target (28% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03923556, a Phase 4 study of Kidney Transplant; Complications and Postoperative Residual Curarization, has completed, sponsored by University of Colorado, Denver.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to compare two medications that reverse muscle paralysis at the end of kidney transplant surgery with the goal of reducing residual muscle weakness and insufficient respiratory function after surgery.
Conditions Studied
Interventions
- DRUG Sugammadex
- DRUG Neostigmine
Study Locations (1)
Colorado
- University of Colorado Hospital - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2021-02-02 |
| Est. Completion | 2023-10-30 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03923556
The ClinicalTrials.gov registry entry for NCT03923556 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 84 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 117-participant average among 19 other Kidney Transplant; Complications trials with a reported enrollment target (28% lower). The listed sponsor is University of Colorado, Denver, which has 1,283 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Kidney Transplant; Complications appearing as the primary indexed condition, and to 2 interventions - of which Sugammadex is the first listed.
NCT03923556 reports 1 study location spanning 1 distinct geographic area - top geographies include Colorado.
Frequently Asked Questions
What is clinical trial NCT03923556 about?
NCT03923556 is a clinical study titled "Sugammadex Versus Neostigmine for Reversal of Neuromuscular Blockade at the End of Kidney Transplantation Surgery". The purpose of this study is to compare two medications that reverse muscle paralysis at the end of kidney transplant surgery with the goal of reducing residual muscle weakness and insufficient respiratory function after surgery.
What is the current status of trial NCT03923556?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 84 participants. The study started on 2021-02-02. Estimated completion is 2023-10-30.
What conditions does trial NCT03923556 study?
This clinical trial studies the following conditions: Kidney Transplant; Complications, Postoperative Residual Curarization, Postoperative Residual Weakness.
What interventions are being tested in trial NCT03923556?
The interventions under investigation include: Sugammadex (DRUG), Neostigmine (DRUG).
Who is sponsoring clinical trial NCT03923556?
This trial is sponsored by University of Colorado, Denver, which has 1,283 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03923556 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Kidney Transplant; Complications
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
RECRUITING · Phase 4
-
Strategic Help With Immunoglobulin to Enhance Protect Against Late Disease (CMV)
RECRUITING · Phase 4
-
Effect of Alkali Therapy on Vascular and Graft Function in Kidney Transplant Recipients
RECRUITING · Phase 4
-
Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants
ACTIVE NOT RECRUITING · Phase 4
-
A Study to Evaluate Preemptive Therapy in Hepatitis C (HCV) Organ Transplant Recipients
ACTIVE NOT RECRUITING · Phase 4
-
Immune Registry for BK in Kidney Transplant Recipients
RECRUITING
Explore more on PlainTrial
Kidney Transplant; Complications
All registered trials for this condition
Postoperative Residual Curarization
All registered trials for this condition
Colorado
All trials with a study site in Colorado
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.